| Study Number |
Title |
| 12993B |
Collection and Use of Mobilized Peripheral Blood Stem Cells from Patients with Hematologic Malignancies
|
| 14736B |
Combined hematologic-cord blood transplantation for adults with hematologic malignancies.
|
| 15147A |
Collection of Research Blood and/or Marrow Samples in Donors Undergoing Bone Marrow, Stem Cell or Lymphocyte Collection.
|
| 15953A |
Protocol for a research database for hematopoietic Stem Cell Transplanation and Marrow Toxic Injuries _ REPLACES 13239B
|
| 15961A |
Protocol for a Research Sample Repository For Allogeneic Hematopioetic Stem Cell Transplanation_ REPLACES 12590A
|
| 09-221-B |
Emergency use of PROCHYMAL (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) for the Treatment of Patients Exposed to an Acute Radiation Dose Sufficient to Elicit the Gastrointestinal Sub-syndrome of the Acute Radiation Syndrome
|
| 09-355-A |
A Multicenter Study of Hematopoietic Stem Cell Donor Safety and Quality of Life
|
| 09-361-A |
A Retrospective Review of Cylopphosphamide and G-CSF Autologous Perpherial Blood Hematopoietic Stem Mobilization (PBSC) in Patiens within Multiple Myeloma Ontcomes Based on Specific Patient Factors
|
| 10-064-B |
Molecular characterization of hematopoietic malignancies
|
| 10-337-B |
A Phase II/III Randomized, Multi-center Trial Comparing Sirolimus plus Prednisone, Sirolimus/Extracorporeal Photopheresis plus Prednisone, and Sirolimus/Calcineurin Inhibitor plus Prednisone for the treatment of Chronic Graft-versus-Host-Disease.
|
| 10-395-A |
CALGB 100701: A Phase II Study of Reduced-Intensity Allogeneic Transplant for Patients with High-Risk Chronic Lymphocytic Leukemia
|
| 10-551-B |
Pilot study T cell depletion in the setting of autologous stem cell transplantation for patients with multiple myeloma
|
| 10-664-B |
A Randomized, Phase III Study Comparing Conventional Dose Treatment Using a Combination of Lenalidomide, Bortezomib and Dexamethasone (RVD) to High-Dose Treatment with Peripheral Stem Cell Transplant in the Initial Management of Myeloma in Patients up to 65 Years of Age (IFM/DFCI 2009)
|
| 11-0118 |
KIR Genotyping for Unrelated Donor (URD) Selection Prior to Hematopoietic Cell Transplantation (HCT) for AML: Selecting a Favorable KIR Donor
|
| 10-372-B |
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of V212 in Recipients of Autologous Hematopoietic Cell Transplants (001)
|
| 11-0322 |
A Randomized, Prospective, Double Blind, Placebo Controlled, Phase 3 Study of US-ATG-F Prophylaxis as a Supplement to Standard of Care Prophylaxis to Prevent Moderate to Severe Chronic GVHD in Adult Acute Myeloid Leukemia, Acute Lymphoid Leukemia, and Myelodysplastic
|
| 11-0270 |
Pharmacokinetics, Safety and Tolerability of Intravenous Posaconazole Solution followed by Oral Posaconazole Suspension (SCH 56592) in Subjects at High Risk for Invasive Fungal Infections (Phase 1B) (P05520)
|
| 12-1191 |
Pilot study of Prophylactic Dose-Escalation Donor Lymphocyte Infusion After T Cell Depleted Allogeneic Stem Cell Transplant in High Risk Patients With Hematologic Malignancies
|
| 12-1856 |
The University of Chicago Transplant Immunology and Immunogenetics Laboratory
Research Registry and Specimen Collection Protocol for Biomedical Research
|
Bone